Controlling the expansion of abdominal aortic aneurysms

British Journal of Surgery

Volumn 90, Issue 8, 2003, Pages 897-898

  Thompson, M M ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MACROLIDE; MATRIX METALLOPROTEINASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ROXITHROMYCIN;

ABDOMINAL AORTA ANEURYSM; EDITORIAL; ENDOVASCULAR SURGERY; HIGH RISK PATIENT; HUMAN; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME; ARTICLE; DISEASE COURSE; PREVALENCE; UNITED KINGDOM;

AORTIC ANEURYSM, ABDOMINAL; DISEASE PROGRESSION; GREAT BRITAIN; HUMANS; PREVALENCE; RISK FACTORS;

EID: 0042921268     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4280     Document Type: Editorial

References (10)

1. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002; 360: 1531-1539.
2. Lederle FA, Johnson GR, Wilson SE, Ballard DJ, Jordan WD Jr, Blebea J et al. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 2002; 287: 2968-2972.
3. UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 1998; 352: 1649-1655.
4. Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002; 346: 1437-1444.
5. Wills A, Thompson MM, Crowther M, Sayers RD, Bell PR. Pathogenesis of abdominal aortic aneurysms - cellular and biochemical mechanisms. Eur J Vasc Endovasc Surg 1996; 12: 391-400.
6. Propranolol Aneurysm Trial Investigators. Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg 2002; 35: 72-79.
7. 2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation 1999; 100: 48-54.
8. Vammen S, Lindholt JS, Ostergaard L, Fasting H, Henneberg EW. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br J Surg 2001; 88: 1066-1072.
9. Axisa B, Loftus IM, Naylor AR, Goodall S, Jones L, Bell PR et al. Prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotid plaques. Stroke 2002; 33: 2858-2864.
10. Baxter BT, Pearce WH, Waltke EA, Littooy FN, Hallett JW Jr, Kent KC et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (phase II) multicenter study. J Vasc Surg 2002; 36: 1-12.